Attenuation of bromobenzene-induced hepatotoxicity by poly(ADP-ribose) polymerase inhibitors.

Research communications in molecular pathology and pharmacology

Volumn 122-123, Issue 1-6, 2009, Pages 79-95

  Hall, Kelly W ^a   Muro Cacho, Carlos ^b   Abritis, Alison ^b   Johnson, Giffe T ^b   Harbison, Raymond D ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BROMOBENZENE; ENZYME INHIBITOR; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, MOUSE; PHENANTHRENE DERIVATIVE; PHENANTHRIDONE; GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

ANIMAL; ARTICLE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; TOXIC HEPATITIS; DRUG-INDUCED LIVER INJURY;

ALANINE TRANSAMINASE; ANIMALS; BROMOBENZENES; DRUG-INDUCED LIVER INJURY; ENZYME INHIBITORS; LIVER; MALE; MICE; MICE, INBRED ICR; NIACINAMIDE; OXIDATIVE STRESS; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES; GLUTATHIONE; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS;

EID: 84856397002     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)